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Abstract
Protein nitration take place on tyrosine residues under oxidative stress conditions and may
influence a number of processes including enzyme activity, protein-protein interactions and
phospho-tyrosine signalling pathways. Nitrated proteins have been identified in a number of
diseases, however, the study of these proteins has been compromised by the lack of good
methods for identifying nitrated proteins, their nitration sites and the level of nitration. Here, we
present a method for identification of nitrated peptides that allows the site specific assignment of
nitration, is easy to use and reproducible, and opens up for the possibility to quantify the level of
nitration of specific peptides as function of different oxidative conditions, namely combined
fractional diagonal chromatography (COFRADIC) in combination with off-line nano-LC-MALDI.
We identify six nitrated peptides from in vitro nitrated bovine serum albumin and propose that
automated COFRADIC using nano-LC and off-line MALDI-MS might be a possibility for
identification of tyrosine nitrated proteins and the nitration sites in complex samples.
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Introduction
Oxidative stress can be induced by an excess of reactiveoxygen species (ROS) and/or reactive nitrogen species
(RNS), and increased RNS can result in protein nitration, the
addition of a nitro-group (-NO2) to the phenol ring of
tyrosine residues [1]. As early as 1966, Sokolovsky et al. [2]
proposed that nitration by agents such as tetranitromethane
could induce changes in protein structure and function; but it
was not until the early 1990’s, when it was discovered that
the biological oxidation of nitric oxide (.NO) generates
strong oxidizing and nitrating intermediates, that the
potential significance of RNS-mediated modifications in
biological processes was appreciated [3, 4].
Protein nitration may have serious consequences, since
the addition of a nitro-group to tyrosine lowers the pKa of
the phenolic hydroxyl-group by 2-3 units, and in addition,
the nitro-group may result in steric hindrance when placed
on relevant tyrosine residues [5]. This means that protein
nitration can affect enzyme activity, protein-protein inter-
action and phospho-tyrosine signalling pathways [6–12].
Protein nitration has been detected in patients suffering
from a number of diseases such as Alzheimer’s disease [13],
atherosclerosis [14], amyotrophic lateral sclerosis [15],
stroke [16], multiple sclerosis [17], cystic fibrosis [18],
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asthma [19] and diabetes [20]. However, the identification of
nitrated proteins and their nitration sites has proved to be a
challenging task. In the majority of these studies, protein
nitration has been detected using immunohistochemistry and
anti-nitrotyrosine antibodies [14, 15, 17, 21]. Unfortunately,
no knowledge about the actual proteins modified or the sites
of modification is obtained from these methods. Nitrated
proteins may be identified in complex biological samples
using 2D-PAGE in combination with western blotting with
anti-nitrotyrosine antibodies and the identity of the proteins
as well as the sites of modification determined by mass
spectrometry (MS). However, only few actual nitration sites
have been recognized using this approach [22–24].
Till now most studies of tyrosine nitrated proteins has been
based on the use of nitrotyrosine specific antibodies resulting
in the identification of the presence of nitrated proteins, but
not in the identification of the proteins and the sites of
modification. We have in our group tested several commercial
antibodies in order to identify nitrated proteins and peptides
and the sites of nitration in proteomics scale experiments.
However, none of them fulfilled our requirements. Alternative
methods to identify nitrated proteins and the nitration sites
using mass spectrometry are therefore of great interest.
Zhan et al. identified nine nitrated proteins and their
nitration sites from a human pituitary adenoma using an
affinity column with anti-nitrotyrosine antibody coupled to
protein G-beads. All nitration sites were found to be located
in positions which potentially could interfere with either
function or structure of the proteins [25]. In order to avoid
the use of antibodies, other approaches for identification of
nitrated proteins have been developed. In an approach based
on strong cation exchange of the peptides derived from
tryptic digestion of brain tissue of healthy and diseased
mice, Sacksteder et al. [26] identified 31 nitration sites in 29
proteins, several of which (chaperones and mitochondrial
proteins) have been shown to have implications with
Parkinson’s disease. Other approaches involve changing
the nitro-group to another chemical group that allows
derivatization with a reagent which can either be efficiently
enriched for or give rise to very specific reporter ions. Zhang
et al. [27] developed a derivatization assay at the peptide
level that through a four-step procedure transformed the
nitro-group into a sulfhydryl-group that could be enriched
using thiopropyl-beads, providing identification of 150
nitration sites in 102 proteins. The method was claimed to
be highly specific, although significant sample losses
occurred due to the multiple steps of derivatization and
subsequent clean-up steps. Amoresano et al. [28] reduced
the nitro-group to an amino-group and then derivatized with
dansyl-chloride creating a product that gives rise to a
specific reporter ion at m/z 170, making it possible to
selectively identify the nitrated peptides. However, although
the reaction is claimed to be specific, the yield of the dansyl-
chloride reaction was only about 60%. Reduction of nitro-
tyrosine to aminotyrosine followed by total protein hydrol-
ysis and amino acid analysis using gas chromatography/
negative chemical ionization tandem mass spectrometry after
derivatization has also been used to quantify nitrotyrosine in
organotypic mesencephalon cultures treated with different
drugs [29]. This method allowed quantitative assessment of
the degree of tyrosine nitration but not identification of the
nitrotyrosine containing proteins and the sites of nitration.
The principle of combined fractional diagonal chromatog-
raphy (COFRADIC) was first described by the group of
Professor Joël Vandekerckhove in 2002 for the isolation of
methionine-containing peptides [30]. The method consists
of two consecutive high performance liquid chromatography
(HPLC) runs with a modification step in-between. Both
specific chemical or enzymatic procedures can be used for the
modification step. The modification must result in a signifi-
cant shift in retention time of the peptides [30] (Figure 1).
The COFRADIC method allows the isolation of specific
peptides from a complex mixture for further analysis, and
has been demonstrated to allow the isolation of a variety of
different peptides, such as methionine- and cysteine-con-
taining peptides, as well as for sialylated N-glycosylated and
N-terminal peptides [30–33]. Recently, Ghesquiére et al.
showed that the COFRADIC approach could also be used to
identify nitrotyrosine containing peptides in both simple and
complex samples [34].
A comprehensive review covering different aspects of
tyrosine nitration and methods for its determination has
recently been published by Abello et al [35]
Materials and Methods
Cytochrome c; bovine serum albumin (BSA); tetranitro-
methane (TNM), Dithiothreitol (DTT); Tris(hydroxymethyl)
aminomethane (Tris); FeCl2; Triton X-100 and α-cyano-4-
hydroxy-cinnamic acid (α-cyano) were obtained from
Sigma-Aldrich, St. Louis, MO, USA. NaCl; NH4HCO3 and
acetic acid were obtained from Sigma-Aldrich, Seelze,
Germany. Acetonitrile was obtained from Sigma-Aldrich,
Steinheim, Germany. Trifluoroacetic acid (TFA) was
obtained from Fluka Chemie, Buchs, Switzerland. NaH2PO4
x H2O and Na2HPO4 x 2H2O were obtained from Merck,
Darmstadt, Germany.
In vitro nitration of BSA was performed as previously
described [36] by dissolving BSA (1-5 mg/ml) in NH4HCO3
(50 mM, pH 9) and adding a 50-fold excess of TNM,
followed by shaking at 1000 rpm at room temperature (RT)
for 1 hr. 10 μl nitrated BSA solution corresponding to 50 -
100 pmoles of starting material was desalted on in-house
packed R3-columns (Oligo R3, Perseptive Biosystems,
Framington, MA, USA) [37], dried down and re-dissolved
in 40 μl reduction/alkylation buffer (NH4HCO3 (20 mM,
pH 9) and 10 mM dithiotreitol (DTT)). The sample was
incubated at 56 °C for 1 hour. 40 μl 55 mM iodoacetamide
was added followed by incubation for 45 min at room
temperature in the dark, and then addition of DTT to a final
concentration of 10 mM. 1 μg chemically modified trypsin
(Promega) was added per 50 μg protein and the sample was
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incubated at RT for 18 hours. The digested sample was
desalted on the above mentioned desalting columns, dried
down and redissolved in 1 ml NH4HCO3 solution (20 mM,
pH 9). This solution served as stock solution for the LC
separations of experiments with nitrated digested BSA. The
native BSA was treated similarly for experiments with non-
nitrated BSA. In all subsequent experiments 10 μl of the stock
solutions corresponding to 0.1-1 pmole of BSA was used.
Reduction with cytochrome c was performed as described
by Ghesquiére et al. [38] with a reduction of the total
volume for the reaction from 100 to 10 μl. The reduction
buffer contained cytochrome c (100 fmol), FeCl2 (2.5 nmol)
in Tris buffer (10 mM, pH 7.4); 20 mM DTT. The reduction
mixture was heated for 2×1 minute at 95 °C with brief
mixing in-between, cooled to RT and acidified with 1 μl
10% TFA solution. The mixture was desalted on an in-house
packed R2 micro-column (Poros 50 R2, Perseptive Bio-
systems, Cambridge, MA, USA), eluted with 50% acetoni-
trile with 0.1% TFA, dried down and redissolved in H2O or
0.06% TFA.
Off-line LC-MALDI of the peptide mixtures was per-
formed as follows: The mixture was separated on an inert
nanoflow-HPLC system (Ultimate; Switchos2; Famos; LC
packings, Amsterdam, The Netherlands) equipped with a
Probot MALDI spotting device (LC Packings, Amsterdam,
The Netherlands). The Samples (10 ul) were loaded onto an
in-house packed 1-cm fused-silica precolumn (100 μm inner
diameter, ReproSil-Pur C18 AQ, 3-mm; Dr. Masch GmbH)
and from this eluted onto an in-house packed 15-cm fused-
silica analytical column (75 μm inner diameter, ReproSil-Pur
C18 AQ, 3-mm; Dr. Masch GmbH) using a flow of 250 nL/
min and a gradient from 100% solvent A (H2O/TFA,
100:0.1, v/v) to 5% solvent B (H2O/acetonitrile/TFA,
20:80:0.1, v/v/v) for 2 minutes, followed by an increase to
40% solvent B in 38 minutes, to 60% solvent B in 2 minutes
and finally to 100% solvent B in 5 minutes. The column
effluent was mixed in a 1:3 ratio with MALDI matrix
solution (3 g/L a-cyano-4-hydroxycinnamic acid in H2O/
acetonitrile/TFA, 30:70:0.1, v/v/v) through a 25 nL mixing
tee (fused-silica capillary TSP050375; Composite Metal
Services Ltd., UK) and spotted in discrete fractions onto a
MALDI target (17 or 20 seconds/fraction). v. 4.5 (Applied
Biosystems).
For COFRADIC, 0.1-1 pmol nitro-BSA peptides was
first separated by nanoLC as described above and collected
in 11 three-minute fractions in a microtiter plate, containing
3 μl Tris-buffer (50 mM, pH 7.4), with a co-flow of
1.051 μl/min Tris-buffer (50 mM, pH 7.4). Fraction
collection was started at 30 min. Each fraction was then
submitted to reduction of the nitro groups to amine groups as
described above and resubmitted to separation by nanoLC
and the effluent spotted onto the MALDI target as described
above.
The spots collected after LC on the MALDI target were
analyzed on an ABI 4800 (Applied Biosystems, Framing-
ham, MA, USA) proteomics analyzer equipped with a 200-
Hz Nd:YAG laser operating at a wavelength of 355 nm.
MALDI-TOF spectra were acquired in reflecting mode
(20 kV accelerating voltage), with 450 ns delayed extraction,
accumulating 1500 laser shots/spot using an automated
COFRADIC t t s ra egy
1st LC run
A B collection interval
time
Modification
2 d LCn  runs
shifted
A
 
peptides Peptides that have not shifted 
from the original fraction and 
therefore are not modified
B
Collect for further analysis
Figure 1. The COFRADIC principle. During the first HPLC run, tryptic peptides are separated and collected in fractions of
appropriate time intervals, depending on the shift in retention time observed after the modification step. The subset of peptides
of interest is then specifically modified, using chemical or enzymatic procedures, followed by a second identical HPLC run
where the modified peptides shift retention time and can be collected for further analysis
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workflow. MS/MS was performed at collision energy of
1 kV and an indicated collision gas pressure of ~1 ×10-6
Torr. The spectra were annotated and the raw files processed
using Data Explorer™ v. 4.5 (Applied Biosystems) and
searched using an in-house MASCOT server (version 2.2)
against our standard protein database (containing BSA and
21 other standard proteins). The following search parameters
were applied: Enzyme: Trypsin; Fixed modifications: Car-
bamidomethyl (C); Variable modifications: oxidation (M)
and nitro (Y) or amino (Y). Mass values: Monoisotopic;
Protein Mass: Unrestricted; Peptide Mass Tolerance: ±
150 ppm; Fragment Mass Tolerance: ± 0.5 Da; Max Missed
Cleavages: 1; Instrument type: MALDI TOF-TOF. Calibra-
tion was only performed for MS spectra (default calibration)
and not for MS/MS, hence the high mass tolerances.
Results and Discussion
Digested samples of BSA, nitrated BSA and nitrated BSA
where the nitro tyrosine was reduced to aminotyrosine were
all submitted to off-line nanoLC MALDI. The mass spectra
obtained from the nitrated BSA sample were all manually
inspected for the three-peak pattern characteristic for nitro-
tyrosine containing peptides (loss of two oxygen atoms), due
to the nitro-group absorbing energy at the wavelength of the
MALDI laser [36, 39] (Figure 2b). Six peptides were
identified (Table 1). Differences in retention times between
the unmodified, nitro- and amino-peptides were determined
by inspecting nano-LC separations of digested BSA, nitro-
BSA and amino-BSA spotted onto a MALDI plate. All the
corresponding six peptides could be identified in the non-
modified form and the aminotyrosine containing form.
Nitration of BSA peptides shifted retention time towards
higher hydrophobicity in the range of 1-3 minutes whereas
reduction of the nitrotyrosine containing peptides to amino-
tyrosine containing peptides shifted the retention time towards
lower hydrophobicity in the range of 4-9 minutes compared to
the corresponding non-modified peptides (Table 2, Figure 2).
The positions and the nature of the modification (nitro- or
amino-group) were verified by MS/MS (Table 1, Figure 3),
with expectation scores G10-5 for all peptides, expect for the
normal and nitrated species of peptide, RPCFSALTPDE-
TYVPK (Y520), where the expectation scores were 910-5.
The efficiency of the reduction of nitrotyrosine to
aminotyrosine with cytochrome c was examined by search-
ing for the six nitro-peptides in the spectra obtained from the
digested amino-BSA sample. None of the six nitro-peptides
could be found indicating that the reduction of nitrotyrosine
to aminotyrosine had been complete (data not shown). The
efficiency of the nitration reaction was examined by
searching for the non-modified peptide in the nitro-BSA
sample. None of the six peptides were 100% nitrated,
although the peptides YLYEIAR (Y161) and YNGVF-
QECCQAEDK (Y184) came close (data not shown). Non-
nitrated peptides in all three samples (normal, nitro- and
amino-BSA) were used to assess the elution time reprodu-
cibility of the individual nano-LC runs. The difference was
found to be within 30 seconds between runs (data not
shown).
A COFRADIC experiment using off-line nanoLC-MALDI
was then performed. The nano-LC separation of the digest of
nitrated BSA was collected in 11 three-minute fractions in a
microtiter plate and the fractions containing five of the six
previously observed nitrotyrosine containing peptides were
identified, reduced, submitted to nanoLC and spotted onto a
MALDI plate. All five peptides shifted, reproducibly, towards
lower hydrophobicity (Table 2). MS/MS verified that the shifted
peptides were the amino species – all with expectation scores
G10-5. Figure 4, shows the results for three of the five peptides.
So far the COFRADIC method has only been performed
using standard HPLC equipment combined with ESI-MS. In
this study, we show that it is possible to perform COFRADIC
experiments using nano-LC combined with off-line MALDI
MS after performing the modification steps in small volumes
(10 μl). In our study, the amounts of sample used were at the
limit or below the sensitivity of UV detection and identification
of the relevant fractions by UV detection was completely
circumvented using only MS to identify relevant fractions.
Using nitrated BSA in low picomolar amounts, we have
demonstrated that COFRADIC in combination with nano-LC
and off-line MALDI MS allow the isolation and identification
of nitrated peptides. The nitrated peptides could be identified in
the first LC separation due to the characteristic three-peak
pattern (loss of two oxygen) that arises because the nitro-group
absorbs energy at the wavelength of the MALDI laser [36, 39].
However, the direct identification of the nitrated peptides based
on the fragmentation upon MALDI will only be possible for
rather simple samples like in this study. The resolution of the
combined chromatographic separation and sampling on the
target plate was sufficient resulting in observation of given
peptides of interest only in three consecutive sample spots on
the MALDI target and the retention time for the nitrated
peptides shifted in a reproducible manner after reduction to
amino-peptides in time frames that make it possible to perform
COFRADIC on complex mixtures.
The proposed set-up for complex mixtures permits both the
analysis of the shifted peptides as well as the non-shifted
peptides, providing a basis for the construction of a protein
library in which the nitrated peptides can be searched.
Furthermore, the reduction reaction enables the analysis of
low-amount biological samples, and the nanoflow-LC system
necessary for this kind of analysis was found to run in a
reproducible manner.
Others have also identified nitrated peptides from in vitro
nitrated BSA, using different MS approaches. Petersson et
al. [36] used ESI-MS/MS and precursor ion scanning for the
immonium ion of nitrotyrosine and found four nitrated
peptides from BSA. Only one of these, the peptide
YLYEIAR (Y161), coincides with the results from this
study, despite the fact that the same protocol for in vitro
nitration of BSA was used. In contrast, three peptides out of
six coincided with a study by Ghesquiére et al. [38]. In this
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study, the nitropeptides were reduced to aminopeptides
followed by acetylation in order to improve fragmentation
and identification. Using the COFRADIC approach,
Ghesquiére et al. [34] observed only one out of four
peptides coinciding with our results. This most likely reflects
irreproducibility of the in vitro nitration procedure rather
than of the methods for isolation and identification of the
nitrated peptides.
Spots on MALDI plate (20 sec) MS spectrum of individual spotsA) B)
BSA, 1502.6, spot 50
600
50 EYEATLEECCAK
500
400
300 normal
200
100
0
30 35 40 45 50 55 60 65 70
30 35 40 45 50 55 60 65 70
30 35 40 45 50 55 60 65 70
Row
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61 NO2
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0
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400
500
300
amino
200
100
0
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Figure 2. Retention time determination and MS analyses for the peptide, EYEATLEECCAK (Y376). The tryptic digests of normal,
nitro- and amino-BSA were separated by nanoflow-LC spotted in 20 second fractions onto a MALDI plate, and the base peak
chromatogram was extracted. (a) The extracted ion chromatograms for the three versions of the peptide, EYEATLEECCAK (Y376).
The spots containing the normal, nitro- and amino-peptide were recognized and used to determine the approximate shifts in
retention time, from normal to nitro-peptides and from nitro- to amino-peptide (Table 2). (b) The MS spectra of the individual spots.
Note the three-peak pattern for the nitro-peptide, corresponding to the loss of two oxygen atoms. Next to the primary peptide,
another nitrated peptide with the characteristic three-peak pattern is seen. Similar results were obtained for five other peptides
Table 1. Peptides observed to be nitrated upon nanoLC-MS and MS/MS of the tryptic digest of BSA, amino-BSA and nitro-BSA
tyrosine BSA Da nitro-BSA
+45 Da
amino-BSA
+15 Da
sequence Verified by MS/MS
Y161 927.46 972.46 942.50 YLYEIAR nitro+amino
Y286 1443.58 1488.54 1458.63 YICDNQDTISSK nitro+amino
Y376 1502.56 1547.58 1517.61 EYEATLEECCAK nitro+amino
Y393 1554.61 1599.56 1569.58 DDPHACYSTVFDK nitro+amino
Y184 1747.66 1792.64 1762.64 YNGVFQECCQAEDK nitro+amino
Y520 1880.85 1925.89 1895.87 RPCFSALTPDETYVPK nitro+amino
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COFRADIC separates the previously nitrated peptides
from the non-nitrated peptides in the second chromato-
graphic run and the nitrated peptides and the nitration sites
can easily be determined, by MS/MS analysis of the sample
spots collected 3-10 minutes before the original fraction.
Maintenance of reproducible retention times in the consec-
utive LC runs can be assessed based on MS or MS/MS of
the peptides eluting at the retention time from the first LC
Table 2. shift in retention times for the five peptides observed to be nitrated
sequence nitro vs. normal peptide amino vs. nitro peptide
YLYEIAR a ~ 2.5 min b ~ 7 min
YICDNQDTISSK a ~ 1.5 min b ~ 4 min
EYEATLEECCAK a ~ 3.5 min b ~ 8 min
DDPHACYSTVFDK a ~ 3 min b ~ 9 min
YNGVFQECCQAEDK a ~ 3 min b ~ 6.5 min
RPCFSALTPDETYVPK a ~ 2.5 min b ~ 6 min
ashift towards higher hydrophobicity
bshift towards lower hydrophobicity
y11y10y9 y8 y7 y6 y5 y4 y3 y2y1
A)
EYEATLEECCAK
1501.96
a1 a2
b2 b3 b4 b5 b7 b8
y4by1 y5 y62 b
y3 y y
a1 a2
3 b5
y2 7 8 y9 y10
y11b4 b7 b8
B) y1y4y5y6y7y8y9 y2y3
EYNO2EATLEECCAK
a1 b2 b3 b7
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y b y6y5
1
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2
y9yy7
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yyyyyyyy yyC) 145678910y11 23 1517.00
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Figure 3. MS/MS verification of the identity of the normal, nitro- and amino-peptide EYEATLEECCAK (Y376). (a) normal
peptide, (b) nitro-peptide, (c) amino-peptide. MS/MS analysis was performed on all normal, nitro- and amino-peptides for
verification of the modifications and their location
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run. The use of automated collection of fractions in micro-
titer plates from the first LC run followed by automated
deposition on the MALDI target in the second LC run opens
for an almost fully automated COFRADIC procedure
provided that the intermediate derivatization procedure can
be performed by a sample preparation robot.
It is still not known whether protein nitration is a primary
event in disease development or whether it is a secondary
event, which can serve as a marker for a disease. In proteins,
where nitration result in gain-of-function, low levels of
nitration may have serious consequences, while a loss-of-
function will require higher levels of nitration before biological
effects take place. This question might be solved using the
described COFRADIC approach because it allows the use of
stable isotope labelling to relatively quantify the level of
protein nitration between diseased versus healthy controls and
possibly also under favourable conditions semi quantification
of the level of nitration on a given site by comparing the signals
for the modified and the non-modified peptides.
Conclusion
We have demonstrated that COFRADIC combined with off-
line nano-LC-MALDI provides an easy and reproducible
method for identifying nitrated proteins from BSA and that
lack of the UV signal from the LC-system need not be a
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Figure 4. COFRADIC of trypsin digested nitrated BSA. Two consecutive HPLC runs with a reduction step in-between were
conducted for nitrated BSA. Eleven three-minute fractions were collected in the first HPLC run, reduced and a second
chromatographic step was performed and the effluent directly spotted onto a MALDI target in 17 second fractions. (a) base
peak chromatograms for two of the four reduced fractions. (b) MS/MS spectra of the shifted peptides in the two fractions,
expectation scores were G10-5. The majority of the peptides in fraction 8 (F8) were located in spots 73-84, wheras the amino-
peptide, YNH2NGVFQECCQAEDK (Y184) was found in spot 53. This peptide could hardly be seen in the base peak
chromatogram but was readily identified based on the mass spectra obtained at the expected retention time. The majority of
the peptides in Fraction 9 (F9) were located in spots 83-96. The amino-peptides, YNH2LYEIAR (Y161)) and DDPHA-
CYNH2STVFDK (Y393) were found at lower retention time in spots 69 and 58, respectively
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limiting factor. COFRADIC as described here can be
performed using very small amounts of sample (low picomolar
range) allowing the analysis of complex real life samples. We
propose that an automated protocol can be made for the
analysis of nitrated peptides in complex samples.
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